GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
Abroad (travel likely)RecruitingEARLY_PHASE1
Conditions
Type 1 Diabetes
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Daniel J Moore, MD, PhD)